Literature DB >> 34819000

Chromone, A Privileged Scaffold in Drug Discovery: Developments in the Synthesis and Bioactivity.

Anjitha Theres Benny1, Sonia D Arikkatt1, Cijo George Vazhappilly2, Sathananthan Kannadasan1, Renjan Thomas3, Manju Sreedharan Nair Leelabaiamma1, Ethiraj Kannatt Radhakrishnan1, Ponnusamy Shanmugam4.   

Abstract

Chromones are the class of secondary metabolites that broadly occur in the plant kingdom in a noticeable quantity. This rigid bicyclic system has been categorized "as privileged scaffolds in compounds" in medicinal chemistry. Their wide biological responses have made them an important moiety in a drug discovery program. This review provides updates on the various methods of synthesis of chromones and biological applications in medicinal chemistry. Various synthetic strategies for the construction of chromones include readily available phenols, salicylic acid and its derivatives, ynones, chalcones, enaminones, and 2-hydroxyarylalkylketones as starting materials. Synthesis of chromones by using metal, metal-free, nanomaterials and different other catalysts is herein included. Details of diverse biological activities of chromone derviatives, such as anti-cancer, antimicrobial, anti-viral, anti-inflammatory, antioxidant, as Monoamine Oxidase-B (MAO-B) inhibitors, anti- Alzheimer's agents, anti-diabetic agents, having antihistaminic potential, and acting as antiplatelet agents, are discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chromones; anti-cancer; anti-diabetic; anti-viral; antimicrobial; synthetic transformation

Mesh:

Substances:

Year:  2022        PMID: 34819000     DOI: 10.2174/1389557521666211124141859

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  1 in total

1.  Synthesis, Experimental and Theoretical Study of Azidochromones.

Authors:  Ena G Narváez-Ordoñez; Kevin A Pabón-Carcelén; Daniel A Zurita-Saltos; Pablo M Bonilla-Valladares; Trosky G Yánez-Darquea; Luis A Ramos-Guerrero; Sonia E Ulic; Jorge L Jios; Gustavo A Echeverría; Oscar E Piro; Peter Langer; Christian D Alcívar-León; Jorge Heredia-Moya
Journal:  Molecules       Date:  2022-04-20       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.